Market expects limited future growth for Chongqing Zhifei Biological Products, contributing to its low P/E ratio. The inferior earnings outlook forms a barrier for the share price.
Last week,$CSOP LOW CARBON US(LCU.SG)$(+1.52% in USD),$CSOP SEA TECH ETF(USD)(SQU.SG)$(+1.17% in USD) and$CSOP STAR&CHINEXT50 SGD(SCY.SG)$(+1.13% in SGD) all gained as Federal Reserve officials issued dovish statements on interest rates. LCU's gains were primarily driven by Japan and China. Among individual firms, the notable gains were observed in Samsung Electronics and TSMC. Samsung Electronics recorded significant growth as its quarterly p...
$Chongqing Zhifei Biological Products(300122.SZ)$ Does this mean, this company will very soon have another share listed? For example there is Pfizer, then they “created” BioNTech. Hualan Biological Engineering's Vaccine Unit Gets Exchange's Nod For IPO Aug 26 (Reuters) - Hualan Biological Engineering Inc <002007.SZ>::SAYS ITS VACCINE UNIT GETS NOD FROM SHENZHEN STOCK EXCHANGE FOR INITIAL PUBLIC SHARE OFFERING. 4 days ago
Chongqing Zhifei Biological Productsに関するコメント
LCU's gains were primarily driven by Japan and China. Among individual firms, the notable gains were observed in Samsung Electronics and TSMC. Samsung Electronics recorded significant growth as its quarterly p...
$シノバク・バイオテク(SVA.US)$ $復星医薬(02196.HK)$ $Shanghai Fosun Pharmaceutical(600196.SH)$ $CanSino Biologics Inc.(688185.SH)$ $康希諾生物(06185.HK)$ $Walvax Biotechnology(300142.SZ)$ $Chongqing Zhifei Biological Products(300122.SZ)$
Does this mean, this company will very soon have another share listed?
For example there is Pfizer, then they “created” BioNTech.
Hualan Biological Engineering's Vaccine Unit Gets Exchange's Nod For IPO
Aug 26 (Reuters) - Hualan Biological Engineering Inc <002007.SZ>::SAYS ITS VACCINE UNIT GETS NOD FROM SHENZHEN STOCK EXCHANGE FOR INITIAL PUBLIC SHARE OFFERING.
4 days ago
まだコメントはありません